Licensed physicians in all 50 states · Free, discreet shipping · Compounded in a US-licensed pharmacy

Comparisons · FAQ

Semaglutide vs tirzepatide: Who may qualify for weight management treatment?

Short answer

For approved adult weight management products, eligibility generally starts at a body mass index of 30, or 27 with a weight-related health condition. These numbers alone do not establish eligibility. A physician licensed in your state must review your health history, medicines, and the risks of semaglutide or tirzepatide.

Approved adult weight management products generally are intended for people with a body mass index, or BMI, of 30 or higher. They may also be used at a BMI of 27 or higher when a person has a weight-related condition, such as high blood pressure or type 2 diabetes. Meeting a BMI cutoff does not mean a prescription is appropriate.

Both drugs have important limits. They should not be used by people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, also called MEN 2. A past serious allergic reaction to the drug is another reason not to use it.

Tell your physician about pancreatitis, gallbladder disease, severe stomach-emptying problems, kidney concerns, or diabetic eye disease. These issues may affect the choice or require closer review.

Pregnancy, plans for pregnancy, and breastfeeding also need discussion. At Verra, a physician licensed in your state reviews these details and decides whether either treatment is appropriate for you.

Sources

Written by the Verra clinical team · Medical review pending

General information, not medical advice. If you're in crisis, call or text 988.

Related guides

Related questions

Your visit pays for itself.

Five minutes online. A physician reviews it within 24 hours, and your $99 visit fee is credited in full toward your first order.

Start your visit

Verra letters

Plain-English health guides, about once a month.

New treatments, honest answers and notes on member pricing. Unsubscribe anytime.